These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 11361847)
1. NDA submitted for new formulation of saquinavir. AIDS Patient Care STDS; 1997 Aug; 11(4):288-9. PubMed ID: 11361847 [No Abstract] [Full Text] [Related]
2. New formulation of saquinavir (Fortovase) is more effective. Tam CW Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126 [TBL] [Abstract][Full Text] [Related]
3. Roche brings new formulation of saquinavir to FDA. Food and Drug Administration. Cadman J GMHC Treat Issues; 1997; 11(4/5):8. PubMed ID: 11364377 [TBL] [Abstract][Full Text] [Related]
4. About the NDA filing. AIDS Patient Care STDS; 1997 Dec; 11(6):455. PubMed ID: 11361869 [No Abstract] [Full Text] [Related]
5. Soft gel saquinavir has high exposure. AIDS Alert; 1997 Dec; 12(12):143-4. PubMed ID: 11364835 [TBL] [Abstract][Full Text] [Related]
6. Roche submits NDA for Invirase. J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796 [TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up. Greenberg RN; Feinberg J; Goodrich J; Pilson RS; Siemon-Hryczyk P Antivir Ther; 2003 Feb; 8(1):37-42. PubMed ID: 12713062 [TBL] [Abstract][Full Text] [Related]
8. Why the old saquinavir (Invirase) may be bad for your health. Vazquez E Posit Aware; 1997; 8(4):28-31. PubMed ID: 11364485 [TBL] [Abstract][Full Text] [Related]
9. Combination suppresses HIV RNA within the central nervous system. AIDS Patient Care STDS; 1998 Jan; 12(1):65. PubMed ID: 11361893 [No Abstract] [Full Text] [Related]
10. Head-to-head study of protease inhibitors. AIDS Patient Care STDS; 1998 Jan; 12(1):63-4. PubMed ID: 11361890 [No Abstract] [Full Text] [Related]
11. Safety profile of soft gelatin formulation of saquinavir in combination with nucleosides in a broad patient population. NV15182 Study Team. Gill MJ AIDS; 1998 Jul; 12(11):1400-2. PubMed ID: 9708428 [No Abstract] [Full Text] [Related]
12. Indinavir (Crixivan): new packaging and strength. Res Initiat Treat Action; 1999 Apr; 5(2):33. PubMed ID: 11366284 [TBL] [Abstract][Full Text] [Related]
13. Combination study of Invirase and Norvir starting. AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361633 [No Abstract] [Full Text] [Related]
14. Fortovase approved: new saquinavir formulation. James JS AIDS Treat News; 1997 Nov; (No 283):1. PubMed ID: 11364907 [TBL] [Abstract][Full Text] [Related]
15. New saquinavir formula more potent than original. Bartnof HS BETA; 1997 Sep; ():45. PubMed ID: 11364701 [TBL] [Abstract][Full Text] [Related]
16. Boosted saquinavir approved. AIDS Patient Care STDS; 2004 Mar; 18(3):183. PubMed ID: 15112642 [No Abstract] [Full Text] [Related]